In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Akzo Nobel divests its UV/EB Resins business
Akzo Nobel acquires full ownership of Asian joint venture
Akzo Nobel agrees to sell 50 percent stake in Flexsys
Akzo Nobel integrates Diosynth and Organon to reinforce its human pharmaceutical
eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
Covance and Lilly Enter Into a Strategic R&D Collaboration